DCN Receives Growth Equity Investment from Martis Capital
TM Capital served as financial advisor to DCN Dx in connection with a growth equity investment from Martis Capital
TM Capital served as financial advisor to DCN Dx in connection with a growth equity investment from Martis Capital
TM Capital arranged $15 million of senior debt financing for International Murex Technologies Corporation (NASDAQ)
TM Capital served as exclusive financial advisor to Canadian Hospital Specialties (“CHS”) in its sale to Cortec Group, a private equity firm with more than $1 billion of capital under management
TM Capital completed the sale of Portland Professional Pharmacy to National Medical Health Card Systems, Inc. (NASDAQ)